Labcorp has joined with the Tigerlily Foundation, a leading breast cancer patient advocacy organization, to increase clinical trial diversity for women of color and co-create health equity solutions. As part of this collaboration, Labcorp signed Tigerlily’s Inclusion Pledge, joining other healthcare and life sciences companies in committing to eradicate barriers for women of color in accessing cancer care and research.

Tigerlily and Labcorp jointly hosted Patient Listening and Clinical Site Listening Summits to discuss health equity and diversity in cancer clinical trials. Attendees included notable and successful diverse site leaders, investigators from Historically Black Colleges and Universities (HBCUs), National Cancer Institute (NCI) Cancer Centers, diversity and inclusion leaders and patients who identify as Black or persons of color to formulate solutions and practices that deliberately put the patient first. Following the listening summits, I AM INCLUDED was developed as a transformational, actionable framework to provide proven and successful actions and serve as a guide for clinical trial site leaders to diversify enrollment in clinical research.

Tigerlily and Labcorp launched I AM INCLUDED, a co- developed, modernized, multi-stakeholder framework for sharing best practices of diverse U.S. clinical trial site leaders for inclusive cancer clinical trials.